Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine/valsartan dose comparison in elderly patients with uncontrolled essential hypertension
2007-004726-24Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amlodipine and valsartan in essential hypertension (3 arms), sponsored by Novartis. Primary endpoint: Primary safety and tolerability endpoint. Started Mar 2008; status: completed.
02
Drugs
amlodipinevalsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2007-004726-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004726-24.